The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Overcoming barriers to adoption of precision medicine in community oncology centers in the rural southeastern United States using novel informatics tools and academic collaborations.
 
Bennett Adam Caughey
No Relationships to Disclose
 
Anivarya Kumar
No Relationships to Disclose
 
Jennifer R. Owen
No Relationships to Disclose
 
Nicholette Sloat
No Relationships to Disclose
 
Elizabeth Maynard
No Relationships to Disclose
 
Vanessa Hill
No Relationships to Disclose
 
Christopher Hubbard
Patents, Royalties, Other Intellectual Property - Molecular Registry of Tumors Software
 
Benjamin Neely
No Relationships to Disclose
 
Matthew Stuart McKinney
Honoraria - Kite/Gilead
Consulting or Advisory Role - BTG; Celgene; Epizyme; Genentech; Kite/Gilead; Molecular Templates; Pharmacyclics; Seagen; Takeda; TG Therapeutics; TG Therapeutics; Verastem
Speakers' Bureau - ADC Therapeutics; BeiGene; Kite/Gilead
Research Funding - Atara Biotherapeutics (Inst); BeiGene (Inst); Celgene (Inst); Genentech (Inst); Incyte (Inst); Janssen Oncology; Loxo/Bayer/Lilly; Molecular Templates (Inst); Nordic Nanovector (Inst); Novartis (Inst); Pharmacyclics (Inst)
 
Linda Sutton
No Relationships to Disclose
 
Shannon J. McCall
Honoraria - Takeda
Consulting or Advisory Role - AstraZeneca
Patents, Royalties, Other Intellectual Property - SciMed Solutions
 
Michael Datto
Research Funding - Foundation Medicine (Inst)
Patents, Royalties, Other Intellectual Property - MRT is intellectual property for which I am the 'inventor'. This software is licensed through Duke.
 
John H. Strickler
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Beigene; Daiichi Sankyo/Astra Zeneca; GlaxoSmithKline; Inivata; Lilly; Natera (Inst); Pfizer; Pionyr; Roche/Genentech; Seagen; Silverback Therapeutics; Takeda; Viatris; Zentalis
Research Funding - A*STAR (Inst); Abbvie (Inst); Amgen (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); BeiGene; Curegenix (Inst); Daiichi Sankyo/Lilly; Erasca, Inc (Inst); Leap Therapeutics (Inst); Lilly (Inst); Nektar (Inst); Roche/Genentech (Inst); Sanofi (Inst); Seagen (Inst); Silverback Therapeutics (Inst)
Travel, Accommodations, Expenses - Seagen
 
Michelle Green
Employment - N-of-One
Research Funding - Bayer (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from SciMed